Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy.
Nosrati, Adi
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy. [electronic resource] - British journal of cancer Apr 2017 - 1141-1147 p. digital
Publication Type: Clinical Trial; Journal Article
1532-1827
10.1038/bjc.2017.70 doi
Age Factors
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Female
Gene Expression Regulation, Neoplastic--drug effects
Humans
Immunotherapy
Ipilimumab
L-Lactate Dehydrogenase--genetics
Male
Melanoma--immunology
Middle Aged
Neoplasm Staging
Nivolumab
Prognosis
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy. [electronic resource] - British journal of cancer Apr 2017 - 1141-1147 p. digital
Publication Type: Clinical Trial; Journal Article
1532-1827
10.1038/bjc.2017.70 doi
Age Factors
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Female
Gene Expression Regulation, Neoplastic--drug effects
Humans
Immunotherapy
Ipilimumab
L-Lactate Dehydrogenase--genetics
Male
Melanoma--immunology
Middle Aged
Neoplasm Staging
Nivolumab
Prognosis
Programmed Cell Death 1 Receptor--antagonists & inhibitors